Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ernexa Therapeutics Inc.

    NASDAQ: ERNA · Real-Time Price · USD
    1.23
    0.05 (4.24%)
    At close: Sep 16, 2025, 2:06 PM

    Ernexa Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.73M 7.58M 11.45M 16.98M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a 4.09M 59K 1M
    Other Long-Term Assets
    		 118K 120K 5.23M 522K
    Receivables
    		 437K 425K 951K 684K
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 186K 1.6M n/a n/a
    Total Current Assets
    		 2.35M 9.6M 13.68M 18.77M
    Property-Plant & Equipment
    		 755K 33.27M 1.27M 3.24M
    Goodwill & Intangibles
    		 2.04M 2.04M 2.04M 8.9M
    Total Long-Term Assets
    		 2.92M 39.53M 8.6M 13.66M
    Total Assets
    		 5.27M 49.13M 22.28M 32.43M
    Account Payables
    		 1.72M 1.07M 1.62M 1.75M
    Deferred Revenue
    		 n/a 190K n/a 1.25M
    Short-Term Debt
    		 207K 2.22M 1.75M 426K
    Other Current Liabilities
    		 12K 773K 2.92M -772K
    Total Current Liabilities
    		 2.94M 6.57M 7.65M 3.68M
    Long-Term Debt
    		 n/a 6.77M 1.21M n/a
    Other Long-Term Liabilities
    		 153K 307K -462K 19.95M
    Total Long-Term Liabilities
    		 630K 40.33M 2.52M 22.25M
    Total Liabilities
    		 3.57M 46.9M 10.17M 25.93M
    Total Debt
    		 684K 41.84M 4.14M 2.72M
    Book Value
    		 n/a n/a n/a n/a
    Book Value Per Share
    		 n/a n/a n/a n/a
    Common Stock
    		 257K 27K 26K 13K
    Retained Earnings
    		 -231.54M -186.98M -165.3M -140.7M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 1.7M 2.23M 12.11M 25.5M
    Total Investments
    		 n/a 4.09M 59K 1M

    Add to Watchlist